These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7905741)

  • 1. Destructive networks in AIDS.
    Kennedy JR
    Immunol Today; 1993 Dec; 14(12):615. PubMed ID: 7905741
    [No Abstract]   [Full Text] [Related]  

  • 2. T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS.
    Zinkernagel RM; Hengartner H
    Immunol Today; 1994 Jun; 15(6):262-8. PubMed ID: 7915115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopathogenesis and immunotherapy in AIDS virus infections.
    Letvin NL; Walker BD
    Nat Med; 2003 Jul; 9(7):861-6. PubMed ID: 12835706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A little learning is a dangerous thing; especially for a cytotoxic T-lymphocyte.
    Griffiths PD
    Rev Med Virol; 2003; 13(5):275-6. PubMed ID: 12931338
    [No Abstract]   [Full Text] [Related]  

  • 5. A strategy for prophylactic vaccination against HIV.
    Salk J; Bretscher PA; Salk PL; Clerici M; Shearer GM
    Science; 1993 May; 260(5112):1270-2. PubMed ID: 8098553
    [No Abstract]   [Full Text] [Related]  

  • 6. [HIV without AIDS but no AIDS without HIV].
    Soriano V; González-Lahoz J
    Med Clin (Barc); 1995 Jul; 105(5):172-3. PubMed ID: 7630229
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular immune responses to HIV.
    McMichael AJ; Rowland-Jones SL
    Nature; 2001 Apr; 410(6831):980-7. PubMed ID: 11309628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lucky ones. How do some HIV-positive people avoid getting AIDS?
    Beardsley T
    Sci Am; 1994 May; 270(5):20, 24, 28. PubMed ID: 7910979
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytotoxic T-cell recognition of HIV proteins and peptides.
    Nixon DF; McMichael AJ
    AIDS; 1991 Sep; 5(9):1049-59. PubMed ID: 1718319
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential pitfalls on the road to an effective HIV vaccine.
    Schwartz DH
    Immunol Today; 1994 Feb; 15(2):54-7. PubMed ID: 7908803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influencing factors of single-platform method of flow cytometry in the detection of immunophenotype of peripheral blood lymphocytes in HIV/AIDS patients].
    Zhang FJ; Yao J; Zhao HX; Feng X; Lu LH; Han N; Liu ZY; Lin H
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):124-6. PubMed ID: 15774223
    [No Abstract]   [Full Text] [Related]  

  • 12. Mucosal immunity, HIV transmission, and AIDS.
    Miller CJ; McGhee JR; Gardner MB
    Lab Invest; 1993 Feb; 68(2):129-45. PubMed ID: 8441249
    [No Abstract]   [Full Text] [Related]  

  • 13. The value of preserving HIV-specific immune responses.
    Kaufmann DE; Rosenberg ES
    J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulation in HIV-1 infection in the HAART era.
    Imami N; Sullivan AK; Gotch FM
    J HIV Ther; 2001 Nov; 6(4):77-84. PubMed ID: 11740408
    [No Abstract]   [Full Text] [Related]  

  • 15. MHC-I non-restricted cytotoxic activity in Macaca sylvana experimentally inoculated with HIV2 and SIV/mac.
    Charaf B; Sanhadji K; Sekkat S; Farouqui B; Touraine JL; Benslimane A
    Thymus; 1993 Aug; 22(1):1-12. PubMed ID: 7905683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-infected humans, but not chimpanzees, have circulating cytotoxic T lymphocytes that lyse uninfected CD4+ cells.
    Zarling JM; Ledbetter JA; Sias J; Fultz P; Eichberg J; Gjerset G; Moran PA
    J Immunol; 1990 Apr; 144(8):2992-8. PubMed ID: 1969880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The infection and immunity of HIV: hope and thought].
    Shang H
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):220-2. PubMed ID: 17425861
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytotoxic T lymphocytes in HIV-induced disease: implications for therapy and vaccination.
    Plata F; Dadaglio G; Chenciner N; Hoffenbach A; Wain-Hobson S; Michel F; Langlade-Demoyen P
    Immunodefic Rev; 1989; 1(3):227-46. PubMed ID: 2698642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS patients can tolerate a substantial loss of CD4 cells.
    Oncology (Williston Park); 1992 Jan; 6(1):97-8. PubMed ID: 1346966
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoregulation, immune defects, and clinical strategies in HIV infection.
    Lane HC
    Mt Sinai J Med; 1992 May; 59(3):244-52. PubMed ID: 1534869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.